Skip to main content
Signal8

Chadwick Jeremy G

SEC insider (Form 3/4/5 filer). CIK 0001388406. Chief Operating Officer at Kymera Therapeutics, Inc. (KYMR). 44 reported Form 4/5 transactions since Sep 2024; latest on May 27, 2026. Located in WATERTOWN, MA.

Companies Chadwick Jeremy G has filed insider reports for

  • Kymera Therapeutics, Inc. (KYMR): Officer, Chief Operating Officer
Chadwick Jeremy G profile photo

Chadwick Jeremy G

CIK: 0001388406

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)32 (72.7%)

Position reduction

Option Exercises (M)10 (22.7%)

Derivative conversions

Awards (A)2 (4.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Kymera Therapeutics, Inc. logo
KYMR

Kymera Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (44 total)

  • Kymera Therapeutics, Inc. logo
    KYMR

    Kymera Therapeutics, Inc.

    May 27, 2026
    Sale
    Direct
    600 shares at avg. $82.08$49K
  • Kymera Therapeutics, Inc. logo
    KYMR

    Kymera Therapeutics, Inc.

    May 27, 2026
    Sale
    Direct
    3.7K shares at avg. $81.50$300K
  • Kymera Therapeutics, Inc. logo
    KYMR

    Kymera Therapeutics, Inc.

    May 26, 2026
    Sale
    Direct
    4.5K shares at avg. $80.02$360K
  • Kymera Therapeutics, Inc. logo
    KYMR

    Kymera Therapeutics, Inc.

    May 26, 2026
    Sale
    Direct
    551 shares at avg. $80.71$44K
  • Kymera Therapeutics, Inc. logo
    KYMR

    Kymera Therapeutics, Inc.

    May 26, 2026
    Sale
    Direct
    3.7K shares at avg. $78.36$292K
  • Kymera Therapeutics, Inc. logo
    KYMR

    Kymera Therapeutics, Inc.

    May 26, 2026
    Sale
    Direct
    3.8K shares at avg. $79.39$302K
  • Kymera Therapeutics, Inc. logo
    KYMR

    Kymera Therapeutics, Inc.

    May 26, 2026
    Sale
    Direct
    324 shares at avg. $79.17$26K
  • Kymera Therapeutics, Inc. logo
    KYMR

    Kymera Therapeutics, Inc.

    Apr 22, 2026
    Exercise
    Direct
    200 shares at avg. $43.50$9K
  • Kymera Therapeutics, Inc. logo
    KYMR

    Kymera Therapeutics, Inc.

    Apr 22, 2026
    Sale
    Direct
    300 shares at avg. $90.00$27K
  • Kymera Therapeutics, Inc. logo
    KYMR

    Kymera Therapeutics, Inc.

    Apr 22, 2026
    Exercise
    Direct
    100 shares at avg. $30.17$3K

1-10 of 44